About Elena E. Giorgi
Research Interests
Viral evolution, diversity, and sequence analysis
Antibody evolution and antibody resistance
Recombination
Phylogenetics
Vaccine design
Current Projects
Recombination in HIV and Coronaviruses
BNAb escape in mother-to-child HIV transmissions
B-cell responses in pediatric SARS-CoV-2 infections
Timing of infection in the AMP clinical trials
HVTN sieve analyses
Epigraph immunogen design for HCV vaccine studies
Popular Content
A new biomarker appears to be an effective surrogate endpoint to reliably predict the ability of broadly neutralizing monoclonal antibodies to prevent acquisition of HIV-1. Broadly neutralizing antibodies (bnAbs) are defined by their ability to neutralize multiple genetically distinct viral strains.